A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
Clinical trial NCT05972044 · COMPLETED
Trial details
- NCT number
- NCT05972044
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2025-02-07
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.